Magneto Thrombectomy Solutions

Magneto Thrombectomy Solutions develops innovative catheter-based devices using proprietary electric field technology to remove blood clots from the vascular system. Their lead product, the eTrieve™ Catheter, has demonstrated safety and efficacy in first-in-human studies for pulmonary embolism by significantly reducing RV/LV ratio and alleviating symptoms. The technology enables strong attachment to blood clots via electrical charge without damaging vessel walls or causing fragmentation. A pivotal international clinical trial (>100 patients) targeting regulatory approval is planned. The company also has early-stage programs targeting ischemic stroke.